Molnupiravir-d7 is the deuterium labeled Molnupiravir. Molnupiravir (EIDD-2801) is an orally bioavailable prodrug of the ribonucleoside analog EIDD-1931. Molnupiravir has broad spectrum antiviral activity againstinfluenza virusand multiple coronaviruses, such as SARS-CoV-2, MERS-CoV,SARS-CoV. Molnupiravir has the potential for the research of COVID-19, and seasonal and pandemic influenza^[1][2].

Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[3].

336.35

Solid

C₁₃H₁₂D₇N₃O₇

Room temperature in continental US; may vary elsewhere.